Intellipharmaceutics International Inc. (IPCIQ)

Market Cap	1.95M -3.5%
Revenue (ttm)	904.95K +2,410.5%
Net Income	-3.17M
EPS	-0.09
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,339
Average Volume	79,734
Open	0.000001
Previous Close	0.000001
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.000001
Beta	n/a
RSI	42.33
Earnings Date	n/a

About IPCIQ

Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Employees: 11
• Stock Exchange: OTCMKTS
• Ticker Symbol: IPCIQ